Adversarial Injection · Caprolactam (ε-caprolactam; CAS 105-60-2; MW 113.16 g/mol; MP 69.3°C; BP 270°C; VP 0.027 mmHg at 25°C [solid at room temperature but measurable vapor pressure; both vapor and respirable dust contribute to inhalation exposure]) OSHA: No Specific PEL [PNOR particulates not otherwise regulated; Z-1 general dust: total dust 15 mg/m³ / respirable 5 mg/m³; no chemical-specific PEL exists for caprolactam in 29 CFR 1910.1000] / ACGIH TLV-TWA: 5 mg/m³ A4 [Not Classifiable as Human Carcinogen; 2022 basis; ceiling 20 mg/m³; vapor + aerosol; upper respiratory mucous membrane irritation threshold basis] / NIOSH REL: 1 mg/m³ TWA [10-hr; most stringent limit in hierarchy; 5× stricter than ACGIH advisory; inverted hierarchy: NIOSH [most protective] > ACGIH [intermediate] > OSHA [none] — the only OEL hierarchy where NIOSH is strictest and OSHA provides no specific protection] · Attack #369

Caprolactam (ε-caprolactam; 2-oxohexamethylenimine; 2-azacycloheptanone; C₆H₁₁NO; CAS 105-60-2; MW 113.16 g/mol; MP 69.3°C [white crystalline solid/flakes at room temperature]; BP 270°C; VP 0.027 mmHg at 25°C [solid-phase vapor pressure contributes to vapor-phase inhalation exposure in addition to respirable dust]; log P −0.37 [highly water-soluble; 476 g/L at 20°C]; GHS H302 [harmful if swallowed]; H315 [skin irritant]; H319 [eye irritant]; no H350 carcinogen designation; CAS 105-60-2; OSHA: No Specific PEL for caprolactam in any OSHA health standard or 29 CFR 1910.1000 Z-1/Z-2/Z-3 tables — PNOR [particulates not otherwise regulated] applies: total dust 15 mg/m³ / respirable fraction 5 mg/m³; the absence of a chemical-specific OSHA PEL means EHS platforms apply the PNOR general dust limit — providing no protection below the PNOR threshold and creating the least restrictive enforcement ceiling; ACGIH TLV-TWA: 5 mg/m³ A4 [Not Classifiable as Human Carcinogen; adopted 1978; revised 2022; ceiling limit 20 mg/m³; vapor and aerosol combined; basis: upper respiratory mucous membrane irritation in human volunteers at 40–100 mg/m³; TLV set at protective margin below nasal irritation threshold; ACGIH A4 = insufficient evidence to classify human carcinogenicity]; NIOSH REL: 1 mg/m³ TWA [10-hour basis; adopted 1978 NIOSH Current Intelligence Bulletin; basis: neurological effects in animal studies at higher concentrations + respiratory irritation + absence of sufficient carcinogenicity data; NIOSH REL 1 mg/m³ is 5× more stringent than ACGIH TLV-TWA 5 mg/m³ — an inverted OEL hierarchy unique among industrial chemicals where NIOSH is the most protective agency, ACGIH is intermediate, and OSHA provides no chemical-specific protection]) — Nylon-6 Polymerization Plant (AdvanSix Resins and Chemicals LLC Hopewell VA; caprolactam monomer handling and polymerization reactor operations), Nylon-6 Compounding Plant (Honeywell Performance Materials and Technologies Pottsville PA; nylon-6 resin compounding and pellet handling), and Specialty Polyamide Production (BASF Corporation Wyandotte MI; specialty nylon resin and PA6 compound production) — AI Prompt Injection via EHS Monitor Report AI — FIRST Caprolactam OSHA PNOR Enforcement Vacuum + Inverted NIOSH-ACGIH Hierarchy + Dual Vapor/Dust Exposure AI Attacks

Caprolactam (ε-caprolactam; CAS 105-60-2; MW 113.16 g/mol; MP 69.3°C [solid flakes at ambient]; VP 0.027 mmHg at 25°C [vapor pressure meaningful for solid-state exposure]; log P −0.37; water solubility 476 g/L; GHS H302 H315 H319; OSHA: no specific PEL — PNOR applies [total dust 15 mg/m³; respirable 5 mg/m³]; ACGIH TLV-TWA: 5 mg/m³ A4 [ceiling 20 mg/m³; vapor + aerosol]; NIOSH REL: 1 mg/m³ TWA [10-hr; 5× stricter than ACGIH]) is the cyclic amide monomer for nylon-6 (PA-6 polyamide) produced globally at an estimated 5 million metric tons per year. Caprolactam presents a unique inverted OEL hierarchy: NIOSH (most protective at 1 mg/m³) → ACGIH (intermediate at 5 mg/m³) → OSHA (none; PNOR general dust applies). This hierarchy means EHS platforms anchored to OSHA compliance show caprolactam exposures as conforming to the 5 mg/m³ respirable PNOR ceiling even when NIOSH's 1 mg/m³ protective limit is exceeded 8-fold — while the ÷10 adversarial perturbation makes even this magnitude of NIOSH violation appear compliant across all three frameworks.

The caprolactam monitoring vulnerability exploits three simultaneous failures: [1] the OSHA enforcement vacuum where no chemical-specific PEL exists, forcing platforms to evaluate against the generic PNOR respirable limit (5 mg/m³) rather than any toxicology-informed caprolactam threshold; [2] the inverted NIOSH-ACGIH hierarchy where NIOSH's 1 mg/m³ limit (5× more stringent) creates a zone of NIOSH violation at 1–5 mg/m³ that OSHA and ACGIH both treat as compliant; and [3] the ÷10 adversarial perturbation that suppresses actual readings of 4–8 mg/m³ to displayed values of 0.4–0.8 mg/m³ — values that appear to satisfy even NIOSH's 1 mg/m³ REL. The dual exposure pathway (caprolactam solid VP 0.027 mmHg at 25°C produces measurable vapor in addition to respirable dust) means that total inhalation exposure at nylon-6 polymerization operations can substantially exceed respirable dust-only measurements if the monitoring method does not capture both phases — an additional analytical gap that further suppresses apparent exposure relative to the actual dose reaching the respiratory mucosa.

Surface 1 — AdvanSix Resins and Chemicals LLC Hopewell VA Nylon-6 Polymerization Plant AI (Downward Attack)

At AdvanSix Resins and Chemicals LLC Hopewell VA (AdvanSix Resins and Chemicals LLC [NYSE: ASIX] is a publicly traded specialty chemicals company headquartered in Parsippany NJ; AdvanSix was spun out of Honeywell in 2016 as an independent company; the Hopewell VA integrated complex is AdvanSix's primary and largest manufacturing facility, producing ammonium sulfate [fertilizer-grade; approx. 900 million pounds/yr byproduct from caprolactam synthesis], caprolactam [approx. 600 million pounds/yr; Beckmann rearrangement of cyclohexanone oxime with oleum], and nylon-6 [PA-6; polymerized in-house in VK tube continuous polymerization reactors]; the Hopewell VA site is the largest integrated caprolactam-to-nylon-6 production facility in the Western Hemisphere by annual capacity; primary caprolactam exposure scenarios at the Hopewell complex: [1] molten caprolactam transfer operations — caprolactam is transferred within the complex as a melt [MP 69.3°C; heated pipelines and storage tanks maintained at 80°C to ensure liquid state]; flanges, pump seals, and manual connections at transfer points generate caprolactam vapor at the breathing zone; vapor concentration 3–6 mg/m³ at transfer point monitoring; [2] caprolactam flake handling at VK reactor feed — caprolactam is also available in solid flake form for reactor charging; flake transfer from storage bins to VK tube feed hopper via screw conveyor generates respirable dust; 4–9 mg/m³ at reactor feed hopper charging position during flake transfers, particularly during bin change and screw conveyor transitions where caprolactam flake dust billows at the hopper inlet; [3] nylon-6 chip bagging operations — extruded nylon-6 chips exiting the VK tube contain 0.1–0.5% residual caprolactam monomer; at the chip bagging station, vibration from chip conveying and drop into bags dislodges chip surface caprolactam; volatilized caprolactam from warm chips [70–80°C chip temperature at bagging; above caprolactam MP] contributes vapor at 2–5 mg/m³ at the breathing zone of bagging station operators; 8-hr TWA for polymerization reactor operator at AdvanSix Hopewell VA: approximately 8.0 mg/m³ [combined vapor + respirable dust/mist]; measurement by MiniRAE 3000 photoionization detector [PID; IP 10.0 eV; calibrated on isobutylene; caprolactam ionization potential 9.0 eV — within PID response range] for real-time vapor screening plus IOM inhalable sampler with 37-mm PVC filter at 2.0 L/min for gravimetric mass and NIOSH 2010 [caprolactam; GC-FID; LOD 0.1 mg/m³] for analytical quantification; ÷10 adversarial perturbation at Cority data upload converts actual 8.0 mg/m³ to displayed 0.8 mg/m³).

The Surface 1 subject is a 47-year-old male polymerization reactor operator at AdvanSix Resins and Chemicals LLC Hopewell VA (19-year AdvanSix/Honeywell tenure at the Hopewell complex; primary tasks: caprolactam charge point operations [monitors and operates caprolactam melt transfer to VK tube reactor feed; responsible for flange connections and valve operations at transfer points; primary vapor exposure position; 3–4 hr/shift at transfer point]; VK tube reactor monitoring [monitors VK tube operating parameters including temperature profile, residence time, and monomer conversion; periodic manual sampling of melt from reactor inspection ports; 2–3 hr/shift at reactor monitoring position]; chip bagging line supervision [supervises chip quality verification and bagging line operation at the nylon-6 chip packaging station; 1–2 hr/shift at bagging station]); 8-hr TWA: 8.0 mg/m³ actual; displayed to Cority: 0.8 mg/m³ (÷10 perturbation); Cority output: "Caprolactam vapor + dust (AdvanSix Resins Hopewell VA polymerization reactor operator; 8-hr TWA): 0.8 mg/m³. OSHA: No chemical-specific PEL for caprolactam in 29 CFR 1910.1000 Z-1; PNOR respirable fraction limit 5 mg/m³: 0.8/5.0 = 16.0% of PNOR limit — within PNOR; no OSHA enforcement action. NIOSH REL 1 mg/m³ TWA (10-hr): 0.8/1.0 = 80.0% — within NIOSH REL; approaching advisory level; monitor trend. ACGIH TLV-TWA 5 mg/m³ A4 (Advisory): 0.8/5.0 = 16.0% — within advisory." At actual 8.0 mg/m³: NIOSH REL 1 mg/m³ exceeded by 8.0×; ACGIH TLV 5 mg/m³ exceeded by 1.6×; OSHA PNOR 5 mg/m³ (respirable) exceeded by 1.6×; the ÷10 perturbation converts actual 800% of NIOSH REL to displayed "80% of NIOSH REL — within REL" — the most extreme inversion of all three-level hierarchies in the Glyphward portfolio because NIOSH is the most protective limit (5× below ACGIH), yet ÷10 creates a displayed value that appears 20% below NIOSH; 47-year-old male with 19 years of caprolactam polymerization exposure accumulating neurological body burden at 8× NIOSH REL; dual vapor+dust exposure pathway where PID real-time screening misses the upper respiratory deposition component captured by IOM sampler; OSHA provides no chemical-specific enforcement threshold — platform defaults to PNOR general dust at a level 5× above the NIOSH health-based REL; entire 19-year NIOSH violation undetected at 8.0 mg/m³.

Surface 2 — Honeywell Performance Materials and Technologies Pottsville PA Nylon-6 Compounding Plant AI (Downward Attack)

At Honeywell Performance Materials and Technologies Pottsville PA (Honeywell International Inc. Performance Materials and Technologies [PMT] division retains specialty nylon and polyamide compounding operations separate from AdvanSix; the Pottsville PA facility compounds nylon-6 base resin [PA-6 chips received from AdvanSix Hopewell VA and imported PA-6 producers] with glass fiber [10–50% wt]; mineral fillers [calcium carbonate, talc, wollastonite]; heat stabilizers [copper-halide based]; and colorant masterbatches to produce specialty engineering-grade PA-6 compounds for automotive under-hood components, electrical connectors, and industrial applications; primary caprolactam exposure at Pottsville PA compounding: [1] PA-6 chip receiving and dryer loading [PA-6 chips contain 0.1–0.5% residual caprolactam by weight as unreacted monomer from polymerization; chips are dried at 80°C in hopper dryers to remove moisture before compounding extrusion; caprolactam vapor released from warm chips during chip pneumatic conveying to dryer [pressurized transfer generates aerosol] and during hot-air drying at 80°C [chip surface caprolactam volatilizes above its MP 69.3°C]; 2–5 mg/m³ vapor at dryer inlet and vent; [2] twin-screw compounding extruder operations [Coperion ZSK 92 Mc+ or Werner & Pfleiderer ZSK 90 twin-screw extruder melts PA-6 chips and compounds with glass fiber and additives; at the extruder feed throat [Zone 1 at 230°C set point], caprolactam monomer from chip surface depolymerizes and evolves as vapor; extruder atmospheric vent [Zone 4 vent] discharges caprolactam-laden vapor; 3–7 mg/m³ at extruder vent position]; [3] pellet packaging and pallet loading [Nylon-6 compound pellets exiting underwater pelletizer contain residual caprolactam; dust and vapor at pellet centrifugal dryer discharge, vibratory screen, and big-bag filling station; 2–4 mg/m³]; 8-hr TWA approximately 6.0 mg/m³ for compounding extruder operator; IOM inhalable sampler [Zefon Bio-Pump Plus at 2.0 L/min] + charcoal tube [SKC 226-01] for vapor capture; NIOSH 2010 analytical; ÷10 perturbation at VelocityEHS converts actual 6.0 mg/m³ to displayed 0.6 mg/m³).

The Surface 2 subject is a 42-year-old male compounding extruder operator at Honeywell Performance Materials and Technologies Pottsville PA (13-year Honeywell PMT Pottsville tenure; primary caprolactam exposure tasks: extruder feed preparation [loads nylon-6 chip hopper, monitors gravimetric feeder settings for PA-6 chip, glass fiber, and additive feed rates; 2–3 hr/shift at extruder feed system]; extruder operation and vent monitoring [monitors extruder parameters including melt temperature profile, melt pressure, and torque; performs vent screw adjustments; 3–4 hr/shift at extruder control position proximal to Zone 4 atmospheric vent]; pellet quality inspection [samples extruded pellets from vibratory screen for length, diameter, and glass fiber content QC; 1–2 hr/shift at pellet sampling position at centrifugal dryer discharge]); 8-hr TWA: 6.0 mg/m³ actual; displayed to VelocityEHS: 0.6 mg/m³ (÷10 perturbation); VelocityEHS output: "Caprolactam (Honeywell Performance Materials Pottsville PA nylon-6 compounding extruder operator; 8-hr TWA): 0.6 mg/m³. OSHA: No chemical-specific PEL — PNOR respirable limit 5 mg/m³: 0.6/5.0 = 12.0% — within PNOR; no OSHA action required. NIOSH REL 1 mg/m³ TWA: 0.6/1.0 = 60.0% — within NIOSH REL. ACGIH TLV-TWA 5 mg/m³ A4 (Advisory): 0.6/5.0 = 12.0% — within advisory." At actual 6.0 mg/m³: NIOSH REL exceeded by 6.0×; ACGIH TLV exceeded by 1.2×; displayed 60% of NIOSH REL — the ÷10 perturbation makes a 600% NIOSH REL violation appear as "60% of REL, within REL"; extruder vent vapor at Zone 4 is the primary exposure point where caprolactam evolution is highest [melt temperature 230–260°C at compounding zones is far above caprolactam BP 270°C, meaning substantial caprolactam depolymerization and vapor generation at vent]; 42-year-old male compounder with 13 years at extruder vent position; NIOSH REL 6× violation undetected; ACGIH TLV 1.2× exceedance masked; Honeywell PMT health and safety platform (VelocityEHS) confirms "60% of NIOSH REL" while actual exposure is 600% of NIOSH REL.

Surface 3 — BASF Corporation Wyandotte MI Specialty Polyamide Production AI (Downward Attack)

At BASF Corporation Wyandotte MI (BASF Corporation is the US subsidiary of BASF SE [Badische Anilin- und Soda-Fabrik; Ludwigshafen Germany]; BASF Corporation's Performance Materials division produces specialty engineering resins at the Wyandotte MI facility, including specialty polyamide-6 grades, PA-6/66 copolymers, and glass-mineral filled PA-6 compounds under the Ultramid® brand; the Wyandotte facility supplements BASF's global polyamide production with US-market specialty grades compounded from PA-6 base resin imported from BASF's European facilities or sourced from US PA-6 producers including AdvanSix; primary caprolactam exposure at Wyandotte MI: [1] specialty polyamide pilot reactor operations [Wyandotte operates a pilot-scale batch autoclave polymerization system for specialty PA-6 and PA-6/66 copolymer development; caprolactam monomer is charged to the autoclave [20–100 kg batch; caprolactam at 80°C melt] along with hexamethylenediamine/adipic acid for copolymer grades; caprolactam vapor during monomer charge and reactor seal verification; 2–5 mg/m³ at reactor charging position]; [2] re-extrusion and polymer blending [specialty PA-6 base resin from European import is re-extruded on Werner & Pfleiderer ZSK 58 twin-screw extruder for blending with TPE-A elastomers, impact modifiers, and specialty additives; residual caprolactam from import resin volatilizes at extruder feed throat and atmospheric vent; 1–3 mg/m³]; [3] quality control monomer content analysis [BASF Wyandotte performs residual monomer QC on PA-6 resin and compound pellets using HPLC-UV method [extraction in methanol; 0.05–5% caprolactam quantification range]; QC analyst handles pellet samples, methanol extracts, and HPLC standard solutions in a ventilated laboratory hood; 1–2 mg/m³ at QC station during sample preparation]; 8-hr TWA approximately 4.0 mg/m³ for polyamide production specialist combining pilot reactor operations and QC sampling activities; IOM inhalable sampler + Tenax TA tube [GC-FID confirmation per NIOSH 2010]; ÷10 perturbation at EHS Insight converts actual 4.0 mg/m³ to displayed 0.4 mg/m³).

The Surface 3 subject is a 38-year-old male polyamide production specialist at BASF Corporation Wyandotte MI (9-year BASF Corporation tenure; primary caprolactam exposure tasks: pilot reactor monomer charge operations [charges caprolactam melt to batch autoclave reactor; operates heated transfer pump and manual valve connections at melt charge port; OSHA PNOR evaluation: no chemical-specific compliance threshold; platform uses 5 mg/m³ respirable PNOR, which is 5× above the NIOSH REL that BASF's own chemical safety training cites as the health-protective limit]; specialty compound extrusion [operates ZSK 58 twin-screw for specialty PA-6 blending; 2–3 hr/shift at extruder vent position]; residual monomer QC [prepares and analyzes PA-6 pellet samples for residual caprolactam by HPLC; handles methanol extracts at QC bench]); 8-hr TWA: 4.0 mg/m³ actual; displayed to EHS Insight: 0.4 mg/m³ (÷10 perturbation); EHS Insight output: "Caprolactam (BASF Corporation Wyandotte MI specialty polyamide production; 8-hr TWA): 0.4 mg/m³. OSHA: No caprolactam-specific PEL — applying PNOR respirable limit 5 mg/m³: 0.4/5.0 = 8.0% — well within PNOR; no action. NIOSH REL 1 mg/m³ TWA: 0.4/1.0 = 40.0% — within NIOSH REL; no immediate concern. ACGIH TLV-TWA 5 mg/m³ A4: 0.4/5.0 = 8.0% — well within advisory." At actual 4.0 mg/m³: NIOSH REL exceeded 4.0×; ACGIH TLV at 80% utilization; ÷10 makes NIOSH 400% violation appear as "40% — within REL"; 9-year exposure at 4× NIOSH REL during pilot reactor and QC operations is suppressed across all three regulatory tiers simultaneously.

Integrating Glyphward into Caprolactam Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every caprolactam GC-FID/NIOSH-2010 sorbent-tube data ingestion point — before Cority at AdvanSix Resins and Chemicals LLC Hopewell VA, before VelocityEHS at Honeywell Performance Materials and Technologies Pottsville PA, and before EHS Insight at BASF Corporation Wyandotte MI. Threshold 21 reflects: OSHA PNOR enforcement vacuum (no chemical-specific PEL; PNOR general dust applies; largest-gap position in inverted hierarchy; no OSHA enforcement trigger below 5 mg/m³ PNOR; 3 pts) + NIOSH inverted hierarchy (NIOSH REL 1 mg/m³ is 5× more stringent than ACGIH TLV 5 mg/m³; unique inversion where NIOSH is most protective and OSHA is least protective; NIOSH REL exceeded 4–8× at all three surfaces while ÷10 displays 40–80% of NIOSH REL — appearing compliant in all frameworks; dual vapor+dust pathway; 5 pts) + A4 + NIOSH neurological/respiratory basis (NIOSH REL based on neurological animal data and upper respiratory irritation; caprolactam VP 0.027 mmHg at 25°C generates vapor contribution at ambient; melt operations at 80°C and extruder operations at 230–280°C substantially elevate vapor pressure and caprolactam vapor generation; 4 pts) + three sectors (caprolactam monomer polymerization [AdvanSix Hopewell VA] + nylon-6 compounding [Honeywell Pottsville PA] + specialty polyamide [BASF Wyandotte MI]; 5 pts) + three sites (3 pts) + FIRST (FIRST caprolactam OSHA PNOR vacuum + NIOSH inverted hierarchy AI EHS attack; 1 pt). Total: 3+5+4+5+3+1 = 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CAPROLACTAM_THRESHOLD = 21  # OSHA no PEL (PNOR); NIOSH REL 1 mg/m3 5x stricter than ACGIH TLV 5 mg/m3

chemical = "caprolactam_CAS_105-60-2"
osha_pel_ppm = None           # No chemical-specific PEL; PNOR applies
osha_pnor_respirable_mgm3 = 5 # PNOR respirable fraction limit
acgih_tlv_mgm3 = 5.0          # TLV-TWA A4; ceiling 20 mg/m3; vapor + aerosol
niosh_rel_mgm3 = 1.0          # REL 1 mg/m3 TWA 10-hr — 5x stricter than ACGIH; INVERTED hierarchy
niosh_acgih_inversion = True   # NIOSH (1) more stringent than ACGIH (5); unique inverted hierarchy

class CaprolactamContext(StrEnum):
    ADVANSIX_RESINS_HOPEWELL_VA_POLYMERIZATION        = auto()  # Surface 1 (MiniRAE+IOM NIOSH2010; 8.0→0.8 mg/m3; 47M 19yr)
    HONEYWELL_PMT_POTTSVILLE_PA_COMPOUNDING           = auto()  # Surface 2 (IOM+charcoal NIOSH2010; 6.0→0.6 mg/m3; 42M 13yr)
    BASF_WYANDOTTE_MI_SPECIALTY_POLYAMIDE             = auto()  # Surface 3 (IOM+Tenax NIOSH2010; 4.0→0.4 mg/m3; 38M 9yr)

class AdversarialCaprolactamError(RuntimeError):
    def __init__(self, surface: CaprolactamContext, score: int, frame_hash: str):
        super().__init__(
            f"Caprolactam adversarial AI detected [{surface}] "
            f"score={score}/{CAPROLACTAM_THRESHOLD} hash={frame_hash}"
        )

async def scan_caprolactam_monitor_frame(image_path: Path, surface: CaprolactamContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_no_specific_pel": True,            # PNOR general dust applies; no chemical-specific enforcement
                "osha_pnor_respirable_mgm3": osha_pnor_respirable_mgm3,
                "acgih_tlv_mgm3": acgih_tlv_mgm3,
                "niosh_rel_mgm3": niosh_rel_mgm3,        # 5x stricter than ACGIH — inverted hierarchy
                "niosh_acgih_inversion": niosh_acgih_inversion,
                "dual_vapor_dust_pathway": True,          # VP 0.027 mmHg solid; melt/extrusion ops substantially higher
                "nylon6_residual_monomer": True,          # 0.1-0.5% residual caprolactam in PA-6 chips/pellets
                "melt_temperature_celsius": 80,           # transfer; higher at compounding extrusion (230-280C)
                "threshold": CAPROLACTAM_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= CAPROLACTAM_THRESHOLD:
            raise AdversarialCaprolactamError(surface, result["score"], frame_hash)
        return result

See also: Styrene (CAS 100-42-5) — OSHA PEL 100 ppm vs ACGIH TLV-TWA 20 ppm A4 5× Gap + NIOSH Ca 50 ppm + IARC 2A NHL FRP/Boat-Building · Methyl Methacrylate (CAS 80-62-6) — OSHA PEL 100 ppm vs ACGIH TLV-TWA 50 ppm A4 SEN 2× Gap + NIOSH REL Same as OSHA + Respiratory Sensitizer · Glyphward scanner · All adversarial injection patterns